Vascular Health and Risk Management

Acute coronary syndrome associated with Churg-Strauss syndrome

Annette Doris Wagner, Gerd Peter Meyer, Markus Rihl, Anke Rathmann, Ulrike Wittkop, et al

Vascular Health and Risk Management 2007, 3:775-779

Published Date: 15 November 2007

Emergency endovascular repair of acute descending thoracic aortic dissection

Muhammad Anees Sharif, Mark Edward O’Donnell, Paul Henry Blair, Peter Kennedy

Vascular Health and Risk Management 2007, 3:769-773

Published Date: 15 November 2007

Magnetic resonance imaging in coronary artery bypass surgery – improvement of global and segmental function in patients with severely compromized left ventricular function

Matthias Thielmann, Peter Hunold, Claudia Böhm, Parwis Massoudy, Heinz Jakob

Vascular Health and Risk Management 2007, 3:763-768

Published Date: 15 November 2007

Rates of symptom reoccurrence after endovascular therapy in subclavian artery stenosis and prevalence of subclavian artery stenosis prior to coronary artery bypass grafting

Brandon A Van Noord, Andrew H Lin, Jeffery J Cavendish

Vascular Health and Risk Management 2007, 3:759-762

Published Date: 15 November 2007

Is general anesthesia a risk for myocardium? Effect of anesthesia on myocardial function as assessed by cardiac troponin-i in two different groups (isofluran+N2O inhalation and propofol+fentanyl iv anesthesia)

Demet Dogan Erol, Ibrahim Ozen

Vascular Health and Risk Management 2007, 3:755-758

Published Date: 15 November 2007

Determinants of outcome in patients eligible for thrombolysis for ischemic stroke

Valeria Caso, Maurizio Paciaroni, Michele Venti, Francesco Palmerini, Giorgio Silvestrelli, et al

Vascular Health and Risk Management 2007, 3:749-754

Published Date: 15 November 2007

Macro- and micronutrients in patients with congestive heart failure, particularly African-Americans

Kevin P Newman, Syamal K Bhattacharya, Ahmad Munir, Richard C Davis, Judith E Soberman, et al

Vascular Health and Risk Management 2007, 3:743-747

Published Date: 15 November 2007

Colesevelam hydrochloride: reducing atherosclerotic coronary heart disease risk factors

Harold Bays, Peter H Jones

Vascular Health and Risk Management 2007, 3:733-742

Published Date: 15 November 2007

A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes

Mozhgan Dorkhan, Anders Frid

Vascular Health and Risk Management 2007, 3:721-731

Published Date: 15 November 2007

Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin

FD Richard Hobbs

Vascular Health and Risk Management 2007, 3:711-719

Published Date: 15 November 2007

Management of intracerebral hemorrhage

Ramandeep Sahni, Jesse Weinberger

Vascular Health and Risk Management 2007, 3:701-709

Published Date: 15 November 2007

Utilizing enoxaparin in the management of STEMI

Andrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale

Vascular Health and Risk Management 2007, 3:691-700

Published Date: 15 November 2007

Optimizing combination treatment in the management of type 2 diabetes

Giuseppe Derosa, Salvadeo Sibilla

Vascular Health and Risk Management 2007, 3:665-671

Published Date: 15 November 2007

Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann’s thrombasthenia

Man-Chiu Poon

Vascular Health and Risk Management 2007, 3:655-664

Published Date: 15 November 2007

Nebivolol in the treatment of chronic heart failure

Angie Veverka, Jennifer L Salinas

Vascular Health and Risk Management 2007, 3:647-654

Published Date: 15 November 2007

A critical review of anti-adrenergic therapy in patients with heart failure and diabetes mellitus

WH Wilson Tang

Vascular Health and Risk Management 2007, 3:639-645

Published Date: 15 November 2007

Ischemic preconditioning: Protection against myocardial necrosis and apoptosis

Efstathios K Iliodromitis, Antigone Lazou, Dimitrios Th Kremastinos

Vascular Health and Risk Management 2007, 3:629-637

Published Date: 15 November 2007

Cholesterol lowering for secondary prevention: What statin dose should we use?

Kiranbir Josan, Finlay A McAlister

Vascular Health and Risk Management 2007, 3:615-627

Published Date: 15 November 2007

Are pleiotropic effects of statins real?

Alberto Corsini, Nicola Ferri, Michele Cortellaro

Vascular Health and Risk Management 2007, 3:611-613

Published Date: 15 November 2007

Aldosterone antagonism in heart failure

Alan B Miller

Vascular Health and Risk Management 2007, 3:605-609

Published Date: 15 November 2007

Comprehensive cardiovascular risk management – what does it mean in practice?

Leif Erhardt, Robert Moller, Juan García Puig

Vascular Health and Risk Management 2007, 3:587-603

Published Date: 15 November 2007

Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension

John D Bisognano, Trent McLaughlin, Craig S Roberts, Simon SK Tang

Vascular Health and Risk Management 2007, 3:579-585

Published Date: 15 November 2007

The role of HMG-CoA reductase inhibition in endothelial dysfunction and inflammation

Paolo Gelosa, Mauro Cimino, Alice Pignieri, Elena Tremoli, Uliano Guerrini, et al

Vascular Health and Risk Management 2007, 3:567-577

Published Date: 15 November 2007

Anti-hemophilic factor (recombinant), plasma/albumin-free method (octocog-alpha; ADVATE®) in the management of hemophilia A

Amy D Shapiro

Vascular Health and Risk Management 2007, 3:555-565

Published Date: 15 November 2007

ISVH Society September Newsletter

Vascular Health and Risk Management 2007, 3:0-0

Published Date: 15 November 2007